What Patients Should Know Before Considering Home Phototherapy
Light has been prescribed for skin disease since the 1920s. The science hasn’t changed much since: hit inflamed skin with the right slice of ultraviolet and the immune cells driving psoriasis, vitiligo, or eczema settle down.
What’s changed is the address. The lamp used to live in a hospital basement, and now it can sit in a spare room, which sounds like an easy win. It mostly is, as long as you know what you’re signing up for.
Not all UV is the same
Most of the ultraviolet spectrum does nothing useful for skin disease. The part that works sits at roughly 311 to 313 nanometres, narrow enough to knock down inflammation without the sunburn baggage older broadband lamps carried.
That’s why narrowband UVB pushed broadband and PUVA aside in British dermatology departments by the mid-2000s. Somewhere around 60 to 70 per cent of plaque psoriasis patients get most of their skin clear after 20 to 36 sessions, though skin type and schedule discipline shift that figure considerably.
Why a dermatologist hands over the lamp
Getting there is the whole problem. Hospital phototherapy means two or three trips a week for two to four months, which is fine if the unit is a bus ride away and close to impossible if you’re 30 miles out with a job that won’t flex. Kit built for UVB Light Therapy at Home takes the travel out of the equation, and attendance usually improves once it does.
The funding picture here looks nothing like the American one. Home units aren’t routinely commissioned, so most UK patients either self-fund or borrow a unit through a hospital loan scheme, and whether that scheme exists at all depends on your trust rather than any national rule.
None of which makes this a shopping decision. Home UVB units are regulated medical devices, and the MHRA is clear about what that means for anything placed on the UK market, which is why a prescription and a supervising dermatologist aren’t optional extras.
The dosing rules are strict on purpose
Prescribed light therapy starts from a dose set by your Fitzpatrick skin type, or by a measured minimal erythema dose if the department does one. From there it climbs maybe 10 to 20 per cent per session. Push too hard and you burn, and a burn costs you weeks.
Miss a week and the dose steps back down rather than resuming where you left off. Goggles stay on for the whole exposure, no exceptions. Men shield the genital area, because the skin cancer risk there is well documented and not theoretical.
Coverage area matters too. A handheld wand is fine for scalp or elbows, but once more than 10 per cent of your body is involved you need a full panel. Swapping between the two halfway through makes a mess of the dose record.
And no, a sunbed isn’t a top-up between sessions. Sunbeds put out mostly UVA, which does very little for plaques while pushing melanoma risk up by roughly 60 per cent in people who start young, which is why the Sunbeds (Regulation) Act 2010 keeps under-18s away from them entirely.
Keep the record, as well. Lifetime UV exposure decides how long you can safely carry on, so doses, session counts and any pinkness afterwards all belong in a log your dermatology team reviews at follow-up.
Some people shouldn’t do this at all
A few conditions close the door outright: lupus, xeroderma pigmentosum, a history of melanoma, and several photosensitivity disorders.
Drugs are the sneakier problem: doxycycline, bendroflumethiazide, some NSAIDs, St John’s wort. Any of them can turn a routine dose into a burn, and people pick up new prescriptions mid-course without thinking to mention it to the dermatology team. Transplant patients on immunosuppressants need their own conversation.
Pregnancy and childhood aren’t automatic disqualifiers, though. Narrowband UVB is one of the few options dermatologists still feel comfortable with during pregnancy. Supervision just gets tighter.
Where that leaves you
Home phototherapy rewards the boring stuff: logging the doses, not getting greedy with the schedule, turning up for reviews after the skin already looks fine. People who treat the unit like a gadget end up burned, or capped out on lifetime exposure years earlier than they needed to be.
The kit itself keeps improving. LED narrowband units are shrinking, apps are quietly replacing paper logs, and several trusts have expanded home loan schemes as dermatology waiting lists stretched past anything anyone would call reasonable. But it still starts with a referral, and that part isn’t going anywhere.
